This article has been corrected: The correct author name is given below:.

Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M., et al. (2018). Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874) [Altro] [10.18632/oncotarget.26431].

Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874)

Cazzaniga M.
Primo
;
Fumagalli A.;Sartori D.;Zambelli A.;Pistelli M.
Penultimo
;
2018

Abstract

This article has been corrected: The correct author name is given below:.
Altro
breast oncology
English
2018
9
36720
36721
Scopus ID 2-s2.0-85089368308
Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M., et al. (2018). Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874) [Altro] [10.18632/oncotarget.26431].
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/301392
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact